Humana Inc (HUM · NYSE)

HUM · MARKET VIEW

Market view · as of Oct 5, 2026

Revenue (TTM)
$145.68B
+26.2% YoY
Gross margin
13.7%
EPS (latest q)
$7.61
vs $6.22 est · beat
52-wk position
91.3%
-5.2% vs 52w high · -4.5% 1mo

Price (last ~year)

Humana shares closed at $388.36, up 2.3% on the day but down 4.5% over the past month, and the company has beaten earnings estimates in each of its last four quarters, including Q2 2026 EPS of $7.61 versus $6.22 expected. Quarterly revenue reached $40.87B in the June quarter, up 26.2% year over year, though operating cash flow was negative at -$426.0M and free cash flow -$558.0M. Margins remain thin — 3.5% operating and 0.9% profit — with debt of $14.25B at 4.0x EBITDA against $6.89B in cash. The company, alongside UnitedHealth, is discontinuing Medicare Advantage plans covering a large share of more than one million seniors for 2027, citing rising medical costs.

Valuation

Market cap
$46.63B
P/E
36.92
PEG
1.254
P/B
2.342
P/S
0.32
Beta
0.745
Analyst target
$423.74

Quality & returns

Gross margin
13.7%
Operating margin
3.5%
Profit margin
0.9%
ROE
6.9%
ROA
3.9%

Price movement

Last
$388.36
1-month
-4.5%
3-month
-2.4%
RSI (14)
40
vs SMA200
+32.8%
52-wk position
91.3% -5.2% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-06-30$40.87B$1.36B$693.0M$1.31B
2026-03-31$39.65B$1.58B$1.19B$1.97B
2025-12-31$32.52B$-1.02B$-796.0M$-685.0M
2025-09-30$32.65B$108.0M$195.0M$480.0M

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots